Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model.
Yamamoto Y, Otsuka A, Nakashima C, Ishida Y, Honda T, Egawa G, Amano W, Usui K, Hamada Y, Wada M, Tanimoto A, Konishi N, Hayashi M, Matsushita M, Kabashima K. Yamamoto Y, et al. Among authors: hayashi m. J Dermatol Sci. 2020 Feb;97(2):161-164. doi: 10.1016/j.jdermsci.2019.12.008. Epub 2019 Dec 20. J Dermatol Sci. 2020. PMID: 31924380 No abstract available.
Pituitary adenylate cyclase-activating polypeptide promotes cutaneous dendritic cell functions in contact hypersensitivity.
Yamamoto Y, Otsuka A, Ishida Y, Wong LS, Seidel JA, Nonomura Y, Nakashima C, Nakajima S, Kitoh A, Nomura T, Dainichi T, Honda T, Amano W, Konishi N, Hayashi M, Matsushita M, Kabashima K. Yamamoto Y, et al. Among authors: hayashi m. J Allergy Clin Immunol. 2021 Sep;148(3):858-866. doi: 10.1016/j.jaci.2021.02.005. Epub 2021 Feb 18. J Allergy Clin Immunol. 2021. PMID: 33609627
Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonist.
Kitagawa Y, Miyai A, Usui K, Hamada Y, Deai K, Wada M, Koga Y, Sakata M, Hayashi M, Tominaga M, Matsushita M. Kitagawa Y, et al. Among authors: hayashi m. J Pharmacol Exp Ther. 2012 Aug;342(2):520-8. doi: 10.1124/jpet.112.194027. Epub 2012 May 15. J Pharmacol Exp Ther. 2012. PMID: 22588258
7,111 results